Form 4: Verizon Executive Reports Stock Transaction

Sentiment:

Insider Transaction Report


Verizon EVP Kyle Malady reported a transaction involving phantom stock units, settled in cash, with an economic equivalent value tied to Verizon's common stock.

Summary

  • Kyle Malady, an Executive Vice President and Group CEO at Verizon Communications Inc., has filed a Form 4 statement detailing a transaction.
  • The transaction involves phantom stock units, which are economically equivalent to a portion of Verizon's common stock and are settled in cash.
  • The earliest transaction date reported is April 9, 2026.
  • Malady acquired 127.53 phantom stock units, with an economic value of $13.63 per unit, totaling $410,769.153.
  • These phantom stocks are held indirectly through a deferred compensation plan.
  • The phantom stock units become payable upon events established by the reporting person under the deferred compensation plan.
  • The filing also notes the inclusion of phantom stock acquired through dividend reinvestment.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details a standard executive compensation transaction rather than significant new financial performance or strategic shifts.

Positives

  • The transaction indicates continued participation and investment in the company's equity-equivalent plans by a key executive.
  • The acquisition of phantom stock, even if settled in cash, suggests a long-term alignment of executive interests with shareholder value.
  • Dividend reinvestment into phantom stock further demonstrates a commitment to accumulating value tied to the company's performance.

Negatives

  • The transaction is a settlement of phantom stock, which is economically equivalent to stock but settled in cash, meaning no direct increase in common stock ownership.
  • The specific details of the 'events established by the reporting person' for payment are not disclosed, leaving potential variability in timing and realization of value.

Risks

  • The value of the phantom stock is directly tied to the performance of Verizon's common stock, meaning a decline in share price would reduce the value of these units.
  • The deferred compensation plan's payout triggers are not fully transparent, introducing a degree of uncertainty regarding the timing of cash realization.

Future Outlook

The future outlook for the value of these phantom stock units is directly dependent on the future performance of Verizon Communications Inc.'s common stock and the specific payout events defined within the deferred compensation plan.

Management Comments

  • Each share of phantom stock is the economic equivalent of a portion of one share of common stock and is settled in cash.
  • The shares of phantom stock become payable upon events established by the reporting person in accordance with the deferred compensation plan.
  • Includes phantom stock acquired through dividend reinvestment.

Industry Context

StockSavvy.ai notes that executive compensation structures involving phantom stock and deferred compensation plans are common within the telecommunications industry, aiming to align executive incentives with long-term company performance and shareholder value.

Stakeholder Impact

  • Shareholders: The transaction reflects executive commitment but does not directly increase the number of outstanding shares or immediate shareholder dilution.
  • Employees: The deferred compensation plan and dividend reinvestment highlight the company's approach to executive incentives, which can influence overall employee morale and retention strategies.
  • Management: Confirms ongoing participation in company incentive plans by a key executive.

Next Steps

  • The phantom stock units will become payable upon events established by the reporting person in accordance with the deferred compensation plan.

Key Dates

DateDescription
04/09/2026Earliest transaction date for phantom stock acquisition.
04/10/2026Date of signature for the filing.

Keywords

Verizon Communications, VZ, Form 4, Insider Trading, Executive Compensation, Phantom Stock, Deferred Compensation, Stock Transaction, Kyle Malady

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.